Abstract
We studied here the antiallergic effect of apple condensed tannins (ACT) administered orally to a type I allergy model mouse transplanted with an IgEL a2 hybridoma secreting anti-2,4,6-trinitrophenyl (TNP) immunoglobulin E (IgE). The oral administration of ACT significantly inhibited the ear swelling responses at 1 h after antigen-stimulation with picryl chloride. The response was dose dependent within 0.1 to 10 mg/mouse. The inhibition of the ear swelling response reached the maximal level (90% inhibition) when ACT was administered 2 h before the antigen challenge. These findings suggest that ACT has an antiallergic effect on type I allergic symptoms.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Allergic Agents / pharmacology*
-
Dose-Response Relationship, Drug
-
Ear, External / pathology
-
Edema / drug therapy
-
Edema / pathology
-
Enzyme-Linked Immunosorbent Assay
-
Female
-
Flavonoids*
-
Histamine H1 Antagonists / pharmacology
-
Hybridomas / pathology
-
Hypersensitivity / drug therapy*
-
Hypersensitivity / pathology
-
Immunoglobulin E / immunology
-
Ketotifen / pharmacology
-
Malus / chemistry*
-
Mice
-
Mice, Inbred BALB C
-
Phenols / chemistry
-
Phenols / pharmacology*
-
Polymers / chemistry
-
Polymers / pharmacology*
-
Polyphenols
Substances
-
Anti-Allergic Agents
-
Flavonoids
-
Histamine H1 Antagonists
-
Phenols
-
Polymers
-
Polyphenols
-
Immunoglobulin E
-
Ketotifen